Contractor Email Archive - Page 271 of 321

Dear Colleague,

CPNI Online ZOOM Contractor Meeting – Thursday 3^rd December 2020 @ 7.30pm

CPNI will host a Contractor Meeting using ZOOM software on Thursday 3^rd December 2020 between 7.30pm and 9pm to provide Contractors with an update on a range of current Community Pharmacy COVID-19 related issues.

As you will be aware a lot has happened since the last CPNI Contractor Zoom Meeting that took place at the start of October; this meeting will provide you with an opportunity to receive an update on the following aspects:

Community Pharmacy Services including Pharmacy First, Flu and COVID-19 Vaccination services, Dispensing and Emergency Supply services.
Community Pharmacy Funding.
Community Pharmacy Operational issues including Christmas Rota, Sit-Rep reports and the implications of staff absences on the ability of pharmacies to open, and EU Exit.

CPNI was delighted with the attendance and the engagement that occurred at the October CPNI Zoom meeting and I would encourage you to make every effort to attend next Thursday’s CPNI Zoom meeting.

Zoom Logon details for the Contractor meeting will be emailed to you at the start of the week.

I look forward to seeing you next week.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

UPDATE

FAO Contractors providing the COMMUNITY PHARMACY SEASONAL FLU VACCINATION (CPFV) SERVICE FOR HEALTH & SOCIAL CARE WORKERS (HSCWS)

Dear Colleague,

Please find attached for your attention, correspondence from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.

Summary:

New allocation of Influenza vaccine available from Monday 30^th November 2020.
The additional allocation will consist of egg-based Quadrivalent Inactivated Vaccine (QIVe) Sanofi Pasteur as opposed to the cell-based Quadrivalent Inactivated Vaccine (QIVc) Flucelvax previously allocated.
The service specification, PGD and supporting documents have been amended to reflect the addition of the Sanofi Pasteur QIVe and can be found at www.pha.site/CPFV.

Action:

Pharmacies are asked to:

Ensure they use existing stock of QIVc Flucelvax in the first instance.
Consider accepting transfer of excess QIVc Flucelvax stock from other pharmacies before placing an order for the Sanofi Pasteur QIVe.
The amended PGD must be signed by the authorising manager and all pharmacists before the eggbased Quadrivalent Inactivated Vaccine (QIVe) can be administered.
The CPFV e-record form has been updated to allow pharmacists to select either the QIVc Flucelvax (cell based) or the QIVe Sanofi Pasteur (egg based) vaccine from Monday 30th November 2020. All staff completing CPFV e-record forms must ensure they select the correct vaccine that has been administered to the patient.
Standard Operating Procedures should be amended to reflect any changes.

If you have any queries please contact either: Chris Blayney (chris.blayney@hscni.net) or Greg Miller (greg.miller@hscni.net) or the CPNI office.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Download

Dear Colleague,

Weekly Alert Summary

Weekly Summary	27.11.2020
Drug alerts available here:	BSO Communications (Drug Alerts)
MPS 2737 – Medicines Recall – Largactil 50mg/2ml sol injection	26^th November 2020
MPS 2736 – Medicines Recall – Betahistine dihydrochloride 8mg and 16mg tab	26^th November 2020
MPS 2735 – Medicines Recall – Abstral 200mcg Sublingual tabs	25^th November 2020
Shortages Information available here:	BSO Shortages Information

Pharmacy team(s) can keep updated with drug information, alerts and shortages information via CPNI’s contractor calendar here or via the BSO website here.

Please bring this to the attention of your pharmacy team(s).

Kind regards,

Kerry

Sent on behalf of Kerry Grimes | Governance & Support Pharmacist

Dear Colleague

COMMUNITY PHARMACY HOME DELIVERY SERVICE DURING THE COVID-19 PANDEMIC – MONTHLY RETURN

Please find attached for your attention, correspondence from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.

SUMMARY:

HSCB are seeking a monthly return detailing the number of deliveries made from commencement of the HSCB commissioned delivery service in September 2020.

ACTION REQUIRED:

The return should be made, preferably by secure e-mail, at the end of each month to the local office email address as detailed below, marking the subject heading as “Delivery service return”.
The email should simply state the number of deliveries made to eligible patients for the relevant month; there is no need to complete a separate proforma. (Alternatively you may wish to use the attached draft return)
Submit a return at the end of November detailing the number of deliveries for September, October and November separately.
A collated return for multiples will be acceptable.
Please note: Details of routine deliveries made through general delivery arrangements are not required.

If you have any queries about this service, please contact your local HSCB office or the CPNI office.

Yours sincerely

Contact Details for Local Integrated Care Offices:

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Download

Dear colleague,

Minister Swann Update on the Planned COVID-19 Vaccination Programme in Northern Ireland

This afternoon Mr Robin Swann MLA, Minister for Health provided an update on the planned COVID-19 vaccination programme in Northern Ireland. The Department of Health press release can be seen here.

Whilst the Minister is clear that the COVID-19 vaccination programme in Northern Ireland still requires regulatory approval the statement confirms that ‘GPs and community pharmacists will also have a key role to play as the programme progresses next year’.

CPNI will continue to engage with the DoH(NI), HSCB and PHA in relation to the arrangements whereby Community Pharmacists will be involved in the vaccination of those in the relevant target groups.

I am sure you will agree this is a welcome development, it demonstrates the further integration of Community Pharmacy as a key part of the Health Service in Northern Ireland at this time and it builds on the professionalism demonstrated by Community Pharmacy teams in the Department of Health’s Seasonal Influenza Vaccination Programme and the wider response by community pharmacy teams to COVID-19 this year.

CPNI will continue to keep you updated on this matter.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Dear Colleagues

SUPERVISION OF OPIOID SUBSTITUTION TREATMENT (OST)

Please find attached for your attention, correspondence from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.

Please do not hesitate to contact your local HSCB office, details included below, should you require any further information or clarification.

Contact Details for Local Integrated Care Offices:

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive